Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Hospira, Inc.    HSP   US4410601003

HOSPIRA, INC. (HSP)

12
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on HOSPIRA, INC.
04/24 HOSPIRA : Leadership Presents at Preeminent European Biosimilars Forum, Announce..
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/18 HOSPIRA : Sets Date for 1st-Quarter 2015 Results Release
04/14 Banks see talent flee amid healthcare M&A boom
04/14 HOSPIRA : Schedules 1st-Quarter 2015 Results Release
04/13 HOSPIRA : Hope for Greater Access for Patients to Biosimilar Medicines
04/10 HOSPIRA : Schedules Date to Report First-Quarter 2015 Results
04/08 Generic drugmaker Mylan offers $29 billion for Perrigo
04/07 HOSPIRA : to Announce First-Quarter 2015 Results on April 28, 2015
04/07 HOSPIRA : BRIEF: FDA: Hospira's corrective actions at Italy plant weren't enough
04/07DJHospira Gets Warning Letter on Quality Issues at Italy Plant
04/07 HOSPIRA : Other Events (form 8-K)
04/01 HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
03/30 HOSPIRA : INFLECTRA™ (Infliximab) Now Available in Canada
03/30 HOSPIRA : INFLECTRA(TM) (Infliximab) Now Available in Canada
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 HOSPIRA : McPherson, Kansas Company Applies to DEA to Import Controlled Substanc..
03/27 HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
03/27 Importer of Controlled Substances Application: HOSPIRA (Importer of Controlle..
03/18 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/15 PFENEX : Reports Fourth Quarter and Full Year 2014 Results and Provides Business..
03/13 HOSPIRA : Chicago Tribune Phil Rosenthal column
03/06 HOSPIRA : Inflectra™ (infliximab) patient registry reports interim results..
03/06 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/06 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/05 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
03/05 Biotech buys get pharma M&A off to flying start in 2015
03/05 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
03/04 BIOGEN IDEC : ISPE Carolina-South Atlantic Chapter Life Sciences Technology Conf..
02/27 HOSPIRA : Other Events (form 8-K)
02/25DJGeneric Copies of Remicade Go on Sale in Europe
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
02/23 HOSPIRA : NYSE:HSP) Investor Alert: Lawsuit Against Takeover Filed
02/19 HOSPIRA : Inflectra(TM) (infliximab) patient registry reports interim results in..
02/18 HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
02/17 HOSPIRA : SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of..
02/17 HOSPIRA : introduces first biosimilar mAb Inflectra in some European markets
02/16 HOSPIRA : Launches Biosimilar Inflectra In Major European Markets
02/16 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (..
02/16 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra(TM) (inf..
02/12DJPainkiller in Short Supply Following Hospira Recall -- Update
02/12 HOSPIRA : earnings hit some targets, miss on others
02/12DJHospira Profit Tops Expectations on Injectables Strength
02/12 HOSPIRA : Management's Discussion and Analysis of Financial Condition and Result..
02/12 HOSPIRA : tops 4Q profit forecasts
02/12 HOSPIRA : Results of Operations and Financial Condition, Financial Statements an..
02/12 HOSPIRA : Reports Fourth-Quarter and Full-Year 2014 Results
02/12 PFIZER : Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of..
02/12 PFIZER : Hospira Cancels Conference Call to Discuss 4th Quarter and Full- Year 2..
02/12 PFIZER : To Acquire Hospira
02/11 HOSPIRA : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf ..
02/11 PFENEX : Hospira to develop and commercialize proposed biosimilar of Lucentis
02/11 HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Commences an Invest..
02/10 HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
02/10 HOSPIRA : to help biosimilar company Pfenex develop vision treatment
02/10 HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
02/10 HOSPIRA : Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP Shar..
02/10 HOSPIRA : Pfenex And Hospira Announce Collaboration To Develop And Commercialize..
02/10 PFIZER : To buy hospira for $15 billion for biosimilars
02/10 PFIZER : Hospira acquisition might fetch pfizer 3 plants in india
02/09 HOSPIRA : Harwood Feffer LLP : Announces Investigation of Hospira, Inc.
02/09 HOSPIRA : Cancels Previously Scheduled Conference Call to Discuss Fourth-Quarter..
02/09 HOSPIRA : Stockholders Encouraged to Contact Securities Law Firm about Takeover
02/09 HOSPIRA : UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigati..
02/09 HOSPIRA : Alert: Takeover of Hospira, Inc. (NYSE:HSP) Under Investor Investigati..
02/09 HOSPIRA : Entry into a Material Definitive Agreement, Change in Directors or Pri..
02/09 Pfizer to buy hospira for $15 billion
02/06 PFIZER : agrees to buy Hospira for $17bn
02/06 HOSPIRA : SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investi..
02/06 HOSPIRA : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr..
02/06 HOSPIRA : Ryan & Maniskas, LLP : Announces Investigation of Hospira Inc.
02/06 HOSPIRA : INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of th..
02/06 HOSPIRA : Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Invest..
02/06 Pfizer to buy Hospira for $15bn
1  2  3  4  5  6  7Next
Advertisement
Chart
Duration : Period :
Hospira, Inc. Technical Analysis Chart | HSP | US4410601003 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF